MG
LONA

Michael Gelband’s LeonaBio Inc LONA Stock Holding History

Michael Gelband’s Portfolio LONA Stock Details LONA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,442
Closed -$135K – 2148
2021
Q3 		$135K Buy
1,442
+372
+35% +$37.9K ﹤0.01% 1859
2021
Q2 		$110K Buy
+1,070
New +$187K ﹤0.01% 2130
2021
Q1 		– Sell
-770
Closed -$264K – 2105
2020
Q4 		$264K Sell
770
-5,924
-88% -$1.4M ﹤0.01% 1598
2020
Q3 		$1.24M Buy
+6,694
New +$1.12M 0.02% 602

Other funds holding LONA

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PFO
Pathstone Family Office Englewood, New Jersey $13.1B AUM 21.02% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Michael Gelband's LONA Position: Q4 2021 in Review

Michael Gelband sold out of LeonaBio Inc (LONA) in Q4 2021, closing a stake of 1,442 shares — an estimated $135K sold.

Michael Gelband first reported a position in LONA in Q3 2020 and held it in 4 quarters. The position peaked at $1.24M in Q3 2020. 104 funds tracked by Wall St. Rank hold LONA as of Q4 2021.

  • Michael Gelband reported no remaining LeonaBio Inc position as of Q4 2021 after selling out during the quarter.
  • Michael Gelband sold 1,442 LeonaBio Inc shares in Q4 2021, an estimated $135K.
  • Michael Gelband first reported a position in LeonaBio Inc in Q3 2020 and held it in 4 quarters.
  • Michael Gelband's LeonaBio Inc position peaked at $1.24M in Q3 2020.
  • 104 funds tracked by Wall St. Rank held LeonaBio Inc as of Q4 2021.

Based on ExodusPoint Capital Management's 13F filing for Q4 2021, filed 11 Feb 2022.